Antibiotic Resistance and Pathogenicity of Bacterial Infections Group
Institut d'Investigació Sanitària Illes Balears (IdISBa) Research Group.
In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa
(0)March 14, 2024 • Latest publication updates, Publications
María A Gomis-Font1 , Miquel À Sastre-Femenia1 , Biel Taltavull1 , Gabriel Cabot1 , Antonio Oliver1 1 Servicio de Microbiología y Unidad de Investigación, Hospital Universitari Son Espases, Instituto de Investigación Sanitaria Illes Balears (IdISBa), CIBERINFEC, Palma de Mallorca, Spain. Objectives: To analyse the dynamics and mechanisms of stepwise resistance development to cefiderocol in Pseudomonas… Read More ›
Recent Stories
- In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants
- Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae
- In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy
- Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones
- A Genomic Snapshot of the SARS-CoV-2 Pandemic in the Balearic Islands
Antibiotic Resistance and Pathogenicity of Bacterial Infections Group 